Evidence map›Paper›PMID 38668041›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features.

Daiken Satake, Manabu Natsumeda, Kaishi Satomi, Mari Tada, Taro Sato, Noritaka Okubo, Keita Kawabe, Haruhiko Takahashi, Yoshihiro Tsukamoto, Masayasu Okada and 11 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Daiken SatakeDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Manabu NatsumedaDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0003-3098-8323
Kaishi SatomiDepartment of Pathology, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan.
Mari TadaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0003-1485-0703
Taro SatoDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Noritaka OkuboDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Keita KawabeDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Haruhiko TakahashiDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Yoshihiro TsukamotoDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0002-2311-5367
Masayasu OkadaDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0002-9151-8184
Masakazu SanoDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
Haruko IwabuchiDepartment of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
Nao ShibataDepartment of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
Masaru ImamuraDepartment of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
Chihaya ImaiDepartment of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.ORCID 0000-0001-7435-3464
Hirokazu TakamiDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Koichi IchimuraDepartment of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Ryo NishikawaDepartment of Neurosurgery/Neuro-Oncology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.ORCID 0000-0001-5617-8068
Hajime UmezuDivision of Pathology, Niigata University Medical and Dental Hospital, Niigata University, Niigata 951-8520, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0003-4244-0277
Makoto OishiDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.ORCID 0000-0002-7060-6396
Niigata University · JPNiigata University Medical and Dental Hospital · JPJuntendo University · JPKyorin University · JPSaitama Medical University · JPUniversity of Tokyo Hospital · JP

Funding

Japan Society for the Promotion of Science 20K09384Japan Society for the Promotion of Science 21KK0156
6 · The paper itself

Abstract

Molecular analysis of the growing teratoma syndrome has not been extensively studied. Here, we report a 14-year-old boy with a growing mass during treatment for a mixed germ cell tumor of the pineal region. Tumor markers were negative; thus, growing teratoma syndrome was suspected. A radical resection via the occipital transtentorial approach was performed, and histopathological examination revealed a teratoma with malignant features. Methylation classifier analysis confirmed the diagnosis of teratoma, and

Indexed as

TeratomaAdolescentBrain NeoplasmsCombined Modality TherapyHumansMalecopy number variation analysisgrowing teratoma syndromemethylation classifiermultimodal treatment

Identifiers

PMID38668041
PMCPMC11049495
OpenAlexW4393386923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.